Publikationen (44) Publikationen von VERÓNICA PILAR AYLLÓN CASES

2023

  1. Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling

    Biomedicine and Pharmacotherapy, Vol. 162

2020

  1. GARP is a key molecule for mesenchymal stromal cell responses to TGF-β and fundamental to control mitochondrial ROS levels

    Stem Cells Translational Medicine, Vol. 9, Núm. 5, pp. 636-650

2019

  1. Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions

    Haematologica, Vol. 104, Núm. 6, pp. 1189-1201

2018

  1. Correction to: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL (Leukemia, (2018), 32, 3, (633-644), 10.1038/leu.2017.294)

    Leukemia

  2. NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL

    Leukemia, Vol. 32, Núm. 3, pp. 633-644

2017

  1. Engineered LINE-1 retrotransposition in nondividing human neurons

    Genome Research, Vol. 27, Núm. 3, pp. 335-348

  2. Establishment of 2 control and 2 hPSC cell lines constitutively expressing the Notch ligand DLL4

    Stem Cell Research, Vol. 25, pp. 274-277

  3. Hoxa9 and EGFP reporter expression in human Embryonic Stem Cells (hESC) as useful tools for studying human development

    Stem Cell Research, Vol. 25, pp. 286-290

  4. New hPSC-based human models to study pediatric Acute Megakaryoblastic Leukemia harboring the fusion oncogene RBM15-MKL1

    Stem Cell Research, Vol. 19, pp. 1-5

  5. RUNX1c Regulates Hematopoietic Differentiation of Human Pluripotent Stem Cells Possibly in Cooperation with Proinflammatory Signaling

    Stem Cells, Vol. 35, Núm. 11, pp. 2253-2266

2016

  1. Erratum: Corrigendum to “Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene” (Stem Cell Research (2016) 16(3) (692–695) (S1873506116300253) (10.1016/j.scr.2016.04.013))

    Stem Cell Research

  2. Generation of human pluripotent stem cell lines with suppressed expression of the Notch ligand DLL4 using short hairpin RNAs

    Stem Cell Research, Vol. 16, Núm. 3, pp. 735-739

  3. Generation of induced pluripotent stem cells (iPSCs) from a Bernard-Soulier syndrome patient carrying a W71R mutation in the GPIX gene

    Stem Cell Research, Vol. 16, Núm. 3, pp. 692-695

2015

  1. Generation and characterization of the human iPSC line PBMC1-iPS4F1 from adult peripheral blood mononuclear cells

    Stem Cell Research, Vol. 15, Núm. 3, pp. 614-617

  2. SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells

    Molecular Therapy, Vol. 23, Núm. 1, pp. 158-170

  3. The Notch ligand DLL4 specifically marks human hematoendothelial progenitors and regulates their hematopoietic fate

    Leukemia, Vol. 29, Núm. 8, pp. 1741-1753

2014

  1. HOXA9 promotes hematopoietic commitment of human embryonic stem cells

    Blood, Vol. 124, Núm. 20, pp. 3065-3075

  2. HRG-1 enhances cancer cell invasive potential and couples glucose metabolism to cytosolic/extracellular pH gradient regulation by the vacuolar-H + ATPase

    Oncogene, Vol. 33, Núm. 38, pp. 4653-4663

  3. Identification of Cdca7 as a novel Notch transcriptional target involved in hematopoietic stem cell emergence

    Journal of Experimental Medicine, Vol. 211, Núm. 12, pp. 2411-2423

  4. Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells

    Leukemia, Vol. 28, Núm. 3, pp. 666-674